Salvage therapy for primary central nervous system lymphoma with ⁹⁰Y-Ibritumomab and Temozolomide

By Pitini Vincenzo   Baldari Sergio   Altavilla Giuseppe   Arrigo Carmela   Naro Claudia   Perniciaro Francesca  

Journal of Neuro-Oncology, Vol. 83, Iss. 3, 2007-07 ,pp. : 291-293

Springer Publishing Company

Access to resources Recommend Favorite

Combined Therapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients

By Ferreri A.J.M.   Reni M.   Bolognesi A.   Verusio C.   Villa E.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2008-2012

Elsevier

Access to resources Recommend Favorite

Secondary Analysis of Radiation Therapy Oncology Group study (RTOG) 9310: An Intergroup Phase II Combined Modality Treatment of Primary Central Nervous System Lymphoma

By Fisher Barbara   Seiferheld Wendy   Schultz Christopher   DeAngelis Lisa   Nelson Diane   Schold S.   Curran W.   Mehta M.  

Journal of Neuro-Oncology, Vol. 74, Iss. 2, 2005-09 ,pp. : 201-205

Springer Publishing Company

Access to resources Recommend Favorite

Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report

By          

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1957-1961

Spandidos Publications

Access to resources Recommend Favorite

Immunochemotherapy for primary central nervous system lymphoma with rituximab, methotrexate, cytarabine and dexamethasone: Retrospective analysis of 18 cases

By                    

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 949-953

Science Publishers

Access to resources Recommend Favorite